Stocks Health care NUS
NYSE · Health careNU Skin Enterprises, Inc. (NUS)
NU Skin Enterprises, Inc. brought in $1.3B of revenue over the twelve months to September 30, 2026, down 15.3% from a year earlier. It posted a net loss of $234.2M. Operating cash flow minus capital spending left $46M of free cash flow in fiscal 2025. At September 30, 2026 it held $164.9M in cash against $203.7M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 6, 2026.
Key facts about NU Skin Enterprises, Inc.
- Net worth
- NU Skin Enterprises, Inc. has a market value (market cap) of $208.3M at the latest share price, and shareholders' equity of $547.5M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $1.5B (-14.3% year on year), with net income of $160.2M. Over the 12 months to September 30, 2026: revenue $1.3B, net loss $234.2M.
- Cash flow
- In fiscal 2025 operations brought in $80.3M of cash; after $34.3M of capital spending, free cash flow was $46M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 6, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- NU Skin Enterprises, Inc.'s next report is expected around February 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What NU Skin Enterprises, Inc. does
NU Skin Enterprises, Inc. is registered with the SEC under industry code SIC 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries). Its shares trade on NYSE under the ticker NUS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.5B | $160.2M | $3.18 | $46M |
| 2024 | $1.7B | -$146.6M | -$2.95 | $70.2M |
| 2023 | $2B | $8.6M | $0.17 | $60.1M |
| 2022 | $2.2B | $104.8M | $2.07 | $49M |
| 2021 | $2.7B | $147.3M | $2.86 | $73M |
| 2020 | $2.6B | $191.4M | $3.63 | $315.3M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where NUS ranks in Health care
Dividends
It paid out $11.8M in cash dividends, 7% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | n/a | $11.8M | 7% |
| 2024 | n/a | $11.9M | n/a |
| 2023 | n/a | $77.6M | 903% |
| 2022 | n/a | $77M | 74% |
| 2021 | n/a | $76.3M | 52% |
| 2020 | n/a | $78.4M | 41% |
Latest SEC filings
What NU Skin Enterprises, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 6, 2026Quarterly report 10-Q · period to September 30, 2026Revenue fell 15% to $311M versus the same quarter last year; diluted EPS -$0.02 versus $0.34.
- November 5, 2026
- August 21, 2026
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 17% to $320.1M versus the same quarter last year; diluted EPS -$5.14 versus $0.43.
- August 10, 2026
- June 1, 2026
- May 29, 2026
- May 21, 2026
- May 14, 2026Passive stake changed SCHEDULE 13G/A
- May 8, 2026
What is NUS worth? A DCF from its reported cash flow
Insider trades
What the people running NU Skin Enterprises, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 9, 2026 | Woodbury Edwina DDirector | Received as pay | 22 | $106.7 |
| June 10, 2026 | Woodbury Edwina DDirector | Received as pay | 19 | $103.2 |
| June 2, 2026 | Winett James MDirector | Soldpre-planned (10b5-1) | 7,203 | $40.5K |
| June 1, 2026 | Campbell Daniel WDirector | Received as pay | 26,643 | - |
| June 1, 2026 | Thomas Pisano R.Director | Received as pay | 26,643 | - |
| June 1, 2026 | Battle Emma S.Director | Received as pay | 26,643 | - |
| June 1, 2026 | Woodbury Edwina DDirector | Received as pay | 26,643 | - |
| June 1, 2026 | Woodbury Edwina DDirector | Soldpre-planned (10b5-1) | 7,203 | $41.1K |
Who owns NUS
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 162 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 4,315,878 | +24,615 |
| American Century Companies Inc | 2,301,308 | +280,106 |
| Coppell Advisory Solutions LLC | 235 | new |
| Vanguard Capital Management LLC | 2,049,641 | -13,709 |
| Dimensional Fund Advisors LP | 1,796,745 | +61,563 |
| Prescott Group Capital Management, L.L.C. | 1,794,608 | 0 |
| Vanguard Portfolio Management LLC | 1,736,856 | +27,303 |
| Renaissance Technologies LLC | 1,607,692 | -92,804 |
| Charles Schwab Investment Management Inc | 1,452,937 | -690,357 |
| CastleKnight Management LP | 1,389,633 | +424,200 |
| Geode Capital Management, LLC | 1,269,191 | +81,025 |
| Two Sigma Investments, LP | 1,168,634 | +156,501 |
| State Street Corp | 1,009,648 | -24,060 |
| Prudential Financial Inc | 926,287 | +549,492 |
| Morgan Stanley | 905,527 | +75,160 |
| Aqr Capital Management LLC | 789,131 | -447,207 |
| Citadel Advisors LLC | 654,577 | +427,192 |
| Goldman Sachs Group Inc | 618,642 | -130,019 |
| Bank of New York Mellon Corp | 542,197 | +1,348 |
| Northern Trust Corp | 415,019 | +13,868 |
Insiders
12 insiders reported holding 2,538,699 shares in total, about $10.9M at the last price.
| Holder | Shares |
|---|---|
| Napierski Ryan SPresident and CEO, Director | 1,001,905 |
| Clark Chayce DavidEVP, COO and CLO | 390,746 |
| Thomas James DChief Financial Officer | 267,102 |
| Hatchett Steven KeithChief Product Officer | 260,818 |
| Keisel Justin SEVP, President of Global Sales | 160,170 |
| Thomas Pisano R.Director | 116,827 |
| Campbell Daniel WDirector | 65,859 |
| Woodbury Edwina DDirector | 62,474 |
| Zorko Mark ADirector | 60,586 |
| Battle Emma S.Director | 57,648 |
Questions about NUS
What does NU Skin Enterprises, Inc. do?
NU Skin Enterprises, Inc. is a company in the Health care sector, listed on NYSE as NUS. Its shares trade on NYSE under the ticker NUS.
What is NU Skin Enterprises, Inc.'s net worth?
NU Skin Enterprises, Inc. has a market value (market cap) of $208.3M at the latest share price, and shareholders' equity of $547.5M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is NU Skin Enterprises, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $234.2M on revenue of $1.3B.
How much revenue does NU Skin Enterprises, Inc. make?
Over the twelve months to September 30, 2026 NU Skin Enterprises, Inc. reported revenue of $1.3B. That is 15.3% less than a year earlier.
When did NU Skin Enterprises, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 6, 2026. It covers the period to September 30, 2026.
When is NU Skin Enterprises, Inc.'s next earnings report?
NU Skin Enterprises, Inc.'s next report is expected around February 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare NUS with
Follow NUS
Get an email when NU Skin Enterprises, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values NU Skin Enterprises, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.